InvestSMART

Regis Healthcare Limited (ASX: REG) - Announcements

Current share price for REG : $6.130 0.16 (2.54%)+

ASX company news and announcements for Regis Healthcare Limited (REG) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Regis Healthcare Limited (REG) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Regis Healthcare Limited (REG), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Regis Healthcare Limited (REG)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$1,853 Regis Healthcare Appointment of Non-Executive Directors 23 Feb 2018 9:12AM $3.800 $6.130 risen by 61.32%
$1,853 Dividend/Distribution - REG 23 Feb 2018 9:10AM $3.800 $6.130 risen by 61.32%
$1,853 Regis Healthcare Investor Presentation 1H FY18 Results 23 Feb 2018 9:07AM $3.800 $6.130 risen by 61.32%
$1,853 Regis Healthcare Results Announcement 1H FY18 23 Feb 2018 9:06AM $3.800 $6.130 risen by 61.32%
$1,853 Regis Healthcare 4D and Financial Report 1H FY18 23 Feb 2018 9:05AM $3.800 $6.130 risen by 61.32%
$1,853 Regis Half Year Results Reporting Date 23 Jan 2018 11:52AM $3.955 $6.130 risen by 54.99%
$1,853 Appendix 3B 18 Dec 2017 1:39PM $3.640 $6.130 risen by 68.41%
$1,853 S&P DJ Indices Announces December Quarterly Rebalance 8 Dec 2017 8:27AM $3.910 $6.130 risen by 56.78%
$1,853 Regis Healthcare- Evans and Partners Conference Presentation 8 Nov 2017 5:39PM $3.670 $6.130 risen by 67.03%
$1,853 Final Director's Interest Notice 8 Nov 2017 9:04AM $3.710 $6.130 risen by 65.23%
$1,853 Regis Healthcare - Results of Annual General Meeting 27 Oct 2017 1:04PM $3.800 $6.130 risen by 61.32%
$1,853 Regis Healthcare - Chairman and MD addresses to AGM 27 Oct 2017 9:36AM $3.810 $6.130 risen by 60.89%
$1,853 Appendix 4G And Corporate Governance Statement 25 Sep 2017 1:18PM $3.420 $6.130 risen by 79.24%
$1,853 Annual Report to shareholders 25 Sep 2017 1:15PM $3.420 $6.130 risen by 79.24%
$1,853 Notice of Annual General Meeting/Proxy Form 25 Sep 2017 1:10PM $3.420 $6.130 risen by 79.24%
$1,853 Appendix 3B 8 Sep 2017 1:29PM $3.325 $6.130 risen by 84.36%
$1,853 Initial Director's Interest Notice 1 Sep 2017 12:49PM $3.320 $6.130 risen by 84.64%
$1,853 Regis Healthcare Board Composition and CEO Remuneration 25 Aug 2017 9:58AM $3.760 $6.130 risen by 63.03%
$1,853 Dividend/Distribution - REG 25 Aug 2017 9:43AM $3.760 $6.130 risen by 63.03%
$1,853 Regis Healthcare Investor Presentation FY2017 Results 25 Aug 2017 9:33AM $3.760 $6.130 risen by 63.03%
$1,853 Regis Healthcare Results Announcement FY2017 25 Aug 2017 9:33AM $3.760 $6.130 risen by 63.03%
$1,853 Regis Healthcare Appendix 4E and Financial Report FY2017 25 Aug 2017 9:30AM $3.760 $6.130 risen by 63.03%
$1,853 AGM Date 14 Aug 2017 10:32AM $3.810 $6.130 risen by 60.89%
$1,853 Notification of Annual Results FY17 Reporting Date 21 Jul 2017 11:08AM $3.690 $6.130 risen by 66.12%
$1,853 Ceasing to be a substantial holder from AMP 20 Jul 2017 3:43PM $3.680 $6.130 risen by 66.58%

301 - 325 of 389 results

Page 13 of 16

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.